Global Demand for Wet Age Related Macular Degeneration (AMD) to Fire up With Higher Incidence of Lifestyle-related Disorders

Published Date : May 08, 2017

ALBANY, New York, May 8, 2017 – has recently added the report titled, Global Wet Age Related Macular Degeneration (AMD) Market: Industry Analysis & Outlook (2017-2021)” to its repository. It evaluates the major catalysts, deterrents, trends, and opportunities in the market, alongside market projections. An assessment of the leading segments of the market, reports of the value chain, and description of the competitive landscape have been included in the report.

Age-related macular degeneration (AMD) is a common condition of the eye that affects vision in people aged 50 and older. There are two basic categories of macular degeneration, dry and wet macular degeneration. Nearly 10 to 15% of the reported cases of macular degeneration are of the ‘wet’ type. In ‘wet’ macular degeneration, growth of abnormal blood vessels, also known as choroidal neovascularization or CNV, takes place under the macula and retina. This causes the macula to lift up or bulge, thus leading to distortion of central vision. Consequently, vision loss can be rapid and severe.

Owing to the phenomenal growth of the geriatric population worldwide, the global market for wet age-related macular degeneration is likely to witness an upsurge over the forthcoming period. In the U.S., one in every seven people is an aged person. The geriatric population was estimated to be 14.5% of the overall population, numbered at 46.2 million in 2014, according to the findings of the Administration for Community Living under the U.S. Department of Health and Human Services. 

For Sample Copy, click here:

The growing prevalence of lifestyle disorders such as obesity, depression, hypertension, and cardiovascular disorders has been driving the market for wet age related macular degeneration market. People in the Asian countries such as India and China are witnessing a high prevalence of the disease. Fortunately, several market players and researchers are developing a number of treatment options. Although repeated treatments are mandatory, doctors are attempting to space the treatments further apart and yet maintain effectiveness. The emergence of personalized medicine has also been aiding the growth of the market.

By geography, North America is expected to hold the leading position in the global market for wet age related macular degeneration. Growth in healthcare infrastructure, high awareness about the disease among people and healthcare providers, and presence of leading market players in the region has been promoting the growth of the wet age related macular degeneration in North America. Asia Pacific is expected to represent a major share in the global market for wet age related macular degeneration in the oncoming years, thanks to the increasing patient pool and rising availability of treatments for wet age related macular degeneration.

The market for wet age related macular degeneration is consolidated in terms of competition. The report profiles the leading market players such as Novartis International AG, Regeneron Pharmaceuticals, Inc., Bayer Group, and Roche Holding AG.

To order report Call Toll Free: 866-997-4948 or send an email on